Showing results (31-40 of 34) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Medicinal Chemistry|October 11, 2011
Discovery of a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) for the treatment of cancerDaniel P Sutherlin, Linda Bao, Megan Berry, et al.Journal of Medicinal Chemistry|May 15, 2013
Lead optimization of a 4-aminopyridine benzamide scaffold to identify potent, selective, and orally bioavailable TYK2 inhibitorsJun Liang, Anne van Abbema, Mercedesz Balazs, et al.ACS Medicinal Chemistry Letters|June 17, 2026
Optimization and <i>In Vivo</i> Characterization of a Series of Cbl‑b Inactive-State InhibitorsMichael J Lambrecht, Jun Liang, Peter Man-Un Ung, et al.Journal of Medicinal Chemistry|September 12, 2017
GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)F Anthony Romero, Jeremy Murray, Kwong Wah Lai, et al.Pageof 4